Medjkane François, Bohet Marine, Ister Marielle, Cohen David, Parenti Aesa, Janati Majda, Mention Karine, Dobbelaere Dries, Jardri Renaud
CHU Lille Service de Psychiatrie Enfants et Adolescents, Centre de Référence des Maladies Rares à Expression Psychiatrique, Hôpital Fontan Lille France.
Service de Pédiatrie Hôpital Victor Provo Roubaix France.
JIMD Rep. 2021 Feb 9;58(1):29-36. doi: 10.1002/jmd2.12133. eCollection 2021 Mar.
Inherited metabolic disorders (IMDs) can present with psychiatric signs that vary widely from one disease to another. This picture is further complicated by the fact that these features occur at very different illness time points, which may further delay appropriate diagnosis and treatment. In this case series of 62 children and adolescents suffering from IMDs, we clustered psychiatric signs (on the basis of the fifth edition of the Diagnostic and Statistical Manual for Mental Disorders classification) as well as impaired cognitive domains (on the basis of the Research Domain Criteriamatrix) according to their mean age of onset (5.7 ± 4 years). We observed consistent patterns of occurrence across disorders. Externalizing symptoms, sleep problems, and cross-domain self-regulation deficits were found to precede the IMD diagnosis. Repetitive thoughts and behaviors as well as emotional dysregulation were found to occur around the disease onset. Finally, late-onset features included dissociative or eating disorders, together with impaired emotion knowledge. Clinicians should specifically look for the co-occurrence of age-specific atypical signs, such as treatment resistance or worsening with psychotropic medication in the earliest stages and symptom fluctuation, confusion, catatonia, or isolated visual hallucinations. We believe that the combined characterizations of psychiatric signs and impaired neurocognitive domains may enable the earliest detection of IMDs and the appropriate care of these particular manifestations.
Psychiatric signs are common in inherited metabolic disorders (IMDs) and may occur in the same age-range as other clinical manifestations.Three clusters of psychiatric signs and two clusters of neurocognitive domains can be defined according to their mean age of onset.Warning signs to be used in liaison psychiatry should include age-specific cognitive impairments.
遗传性代谢疾病(IMD)可表现出因疾病而异的广泛精神症状。由于这些特征出现在非常不同的疾病时间点,情况变得更加复杂,这可能会进一步延迟适当的诊断和治疗。在这个包含62名患有IMD的儿童和青少年的病例系列中,我们根据精神障碍诊断与统计手册第五版分类将精神症状以及根据研究领域标准矩阵划分的认知领域受损情况,按照其平均发病年龄(5.7±4岁)进行了聚类。我们观察到不同疾病中存在一致的症状出现模式。外化症状、睡眠问题和跨领域自我调节缺陷在IMD诊断之前出现。重复思维和行为以及情绪调节障碍在疾病发作时出现。最后,晚发性特征包括解离性或饮食障碍,以及情绪知识受损。临床医生应特别留意特定年龄的非典型症状的共现情况,例如在最早阶段对精神药物治疗的抵抗或病情恶化,以及症状波动、意识模糊、紧张症或孤立的视幻觉。我们认为,精神症状和神经认知领域受损的综合特征可能有助于最早发现IMD并对这些特殊表现进行适当护理。
精神症状在遗传性代谢疾病(IMD)中很常见,可能与其他临床表现出现在相同年龄范围。
根据平均发病年龄可定义出三类精神症状和两类神经认知领域。
联络精神科应使用的警示信号应包括特定年龄的认知障碍。